Clinical & Medical Genomics Services
World-class genomic testing supporting precision medicine, oncology, and hereditary disease management.
Introduction
Yaazh Xenomics brings world-class Medical Genomics capabilities to hospitals, oncologists, genetic counselors, and clinical diagnostics partners across India. Our clinical genomic testing services are designed to support precision medicine, hereditary cancer risk assessment, targeted therapy decisions, and comprehensive patient management.
We combine cutting-edge sequencing platforms (Illumina NovaSeq X Plus, AVITI & Oxford Nanopore) with expert bioinformatics and clinically relevant reporting to deliver high-quality, actionable results that integrate seamlessly into your clinical workflow.
Workflow / Steps
Sample Collection
We provide collection kits or accept samples directly (blood, FFPE, stool).
Logistics Support
Pan-India sample pickup and transport coordination available.
Processing & Analysis
Performed on Illumina NovaSeq X Plus / Nanopore with rigorous quality control.
Clinical Reporting
Detailed, clinically actionable reports delivered within 3 weeks.
Support
Dedicated clinical genomics team available for report discussion and queries.
Why Hospitals & Clinicians Choose Yaazh Xenomics
Clinical-Grade Reports
Comprehensive clinical interpretation aligned with international standards
Fast Turnaround
Consistent 3-week TAT across most tests
Flexible Specimen Options
Peripheral blood (EDTA), FFPE blocks/sections, and stool samples
Advanced Platforms
Illumina NovaSeq X Plus (high accuracy, deep coverage), AVITI + Nanopore long-read technology
B2B / Institutional Focus
Special pricing and dedicated support for hospitals, diagnostic chains, and healthcare institutions
End-to-End Support
Sample logistics, technical queries, and post-report clinical discussion support
Comprehensive Portfolio
From targeted hereditary cancer panels to Whole Exome and Whole Genome Sequencing
All services include Clinical Reports. Most tests are performed on Illumina NovaSeq X Plus & AVITI platform (except Gut Microbiome – Nanopore).
1. Whole Exome & Whole Genome Sequencing
| Test | Platform & Key Specifications | Specimen | TAT | MRP |
|---|---|---|---|---|
| Whole Exome Sequencing (Germline) | Illumina NovaSeq X Plus 19,433 genes (coding regions) 100X Coverage • 6-8 Gb Data Clinical Report | FFPE Block / Sections | 3 Weeks | ₹20,000 |
| Whole Exome Sequencing (Somatic) | Illumina NovaSeq X Plus 19,433 genes (coding regions) 300X Coverage • 18-20 Gb Data Clinical Report | Peripheral blood in EDTA (5 ml) | 3 Weeks | ₹28,500 |
| Human Whole Genome Sequencing | Illumina NovaSeq X Plus 30x Coverage • 100 Gb Data Clinical Report + PGx Report | Peripheral blood in EDTA (5 ml) | 3 Weeks | ₹95,000 |
2. Comprehensive Hereditary & Disease-Specific Panels
| Test | Key Genes Covered | Specimen | TAT | MRP |
|---|---|---|---|---|
| Comprehensive Hereditary Panel | 400+ Genes | Peripheral blood in EDTA (5 ml) | 3 Weeks | ₹28,500 |
3. Hereditary Cancer Susceptibility & Oncology Panels
All panels below are offered at the same attractive B2B pricing:
| Test | Key Genes | MRP |
|---|---|---|
| High Penetrance Breast Cancer Susceptibility Testing | BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, TP53, ATM, BARD1, CHEK2, RAD51C, RAD51D, NF1 | ₹17,500 |
| Ovarian Cancer Susceptibility Panel | ATM, BRCA1, BRCA2, BRIP1, MLH1, MSH2, MSH6, EPCAM, PALB2, RAD51C, RAD51D, PMS2 | ₹17,500 |
| Homologous Recombination Repair (HRR) Germline Panel | CDK12, CHEK2, RAD51C, BARD1, BRCA1, RAD54L, BRCA2, BRIP1, PPP2R2A, ATM, CHEK1, FANCL, RAD51B, PALB2, RAD51D | ₹17,500 |
| Prostate Cancer Susceptibility Testing Panel | ATM, BRCA1, BRCA2, CHEK2, HOXB13, EPCAM, MLH1, MSH2, MSH6, PMS2, PALB2 | ₹17,500 |
| Pancreatic Cancer Susceptibility Testing Panel | ATM, BRCA1, BRCA2, CDKN2A, MLH1, MSH2, MSH6, EPCAM, PALB2, STK11, TP53, PMS2, APC, CDK4 | ₹17,500 |
| Inherited Gastrointestinal Oncology Panel | ATM, AXIN2, BMPR1A, CDH1, CHEK2, CTNNA1, EPCAM, GREM1, KIT, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NTHL1, PDGFRA, PMS2, POLD1, POLE, PTEN, RNF43, SMAD4, STK11, TP53, APC, SDHA, SDHAF2, SDHB, SDHC, SDHD, NF1 | ₹17,500 |
| Inherited Wilms Tumor Panel | BLM, BUB1B, CDC73, DIS3L2, GPC3, REST, TP53, TRIP13, WT1, TRIM28, FBXW7, NYNRIN, KDM3B, XPO5, CHEK2, PALB2, DICER1 | ₹17,500 |
| Neurofibromatosis Panel | NF1 & NF2 | ₹17,500 |
| Inherited Renal Cancer Panel | BAP1, DICER1, FH, FLCN, MET, MITF, PTEN, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMARCA4, SMARCB1, TMEM127, TP53, TSC1, TSC2, VHL | ₹17,500 |
| Inherited Endocrine Cancer Panel | AIP, APC, CDC73, CDKN1B, DICER1, FH, MAX, MEN1, NF1, PHOX2B, PRKAR1A, PTEN, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, TP53, TSC1, TSC2, VHL, WRN | ₹17,500 |
| Inherited Thyroid Cancer Panel | APC, DICER1, PRKAR1A, PTEN, RET, TP53, WRN | ₹17,500 |
4. Microbiome Testing
| Test | Platform & Details | Specimen | TAT | MRP |
|---|---|---|---|---|
| Gut Microbiome | Oxford Nanopore 2-3 Gb Data • Clinical Report | Stool Sample | 3 Weeks | ₹9,900 |
B2B & Institutional Partnership Benefits
- Attractive B2B / Hospital pricing (as shown above)
- Volume-based discounts and customized packages for hospitals & diagnostic chains
- Dedicated account manager and technical support
- Integration support with hospital LIS/HIS (on request)
- Co-branded reporting options available
- Regular scientific updates and training sessions for your clinical team
Who Should Order These Tests?
Oncologists & Oncology Departments:
Genetic Counselors & Genetic Clinics:
Medical Geneticists:
Nephrologists & Endocrinologists (for syndrome-specific panels):
Preventive Health & High-Risk Screening Programs:
Hospitals offering precision medicine & personalized treatment:
Pathology labs & diagnostic centers (as referral partner):